Home »
Preliminary results of a phase 3, randomized, placebo-controlled clinical trial testing the investigative monoclonal antibody LY-CoV555 in hospitalized COVID-19 patients …
Interim results of the Oxford COVID-19 vaccine trials find that the vaccine protects against symptomatic disease in 70% of cases—with …
The first vaccines are only weeks away but the winter is looking bleak for the United States, where the coronavirus …
13 November 2020 — GlaxoSmithKline plc (GSK) today announced further progression in its R&D pipeline with presentation of data for …
US biotech firm Moderna reported “positive interim” results on Monday in the first clinical tests of its vaccine against the …
AUSTIN, Texas, March 05, 2019 (GLOBE NEWSWIRE) — XBiotech (NASDAQ: XBIT) today released findings for its Phase 2 clinical study …